CA 125 half-life breakpoint between a "good" and "poor" prognosis in patients with ovarian cancer.
Mano
A
A
Laboratory of Pharmacology, Faculty of Pharmacy, University of Coimbra, 3000-295 Coimbra, Portugal.
Godinho
I
I
Falcão
A C
AC
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D018394:CA-125 Antigen / Q000097:blood*; D005260:Female; D006207:Half-Life; D006801:Humans; D008875:Middle Aged; D010051:Ovarian Neoplasms / Q000097:blood* / Q000401:mortality; D011379:Prognosis; D016019:Survival Analysis
D018394:CA-125 Antigen